Show simple item record

Authordc.contributor.authorSir Petermann, Lidia 
Authordc.contributor.authorEchiburú López, Bárbara 
Authordc.contributor.authorCrisosto King, Nicolás 
Authordc.contributor.authorMaliqueo Yevilao, Manuel 
Authordc.contributor.authorPérez Bravo, Francisco 
Admission datedc.date.accessioned2017-11-28T16:06:41Z
Available datedc.date.available2017-11-28T16:06:41Z
Publication datedc.date.issued2016
Cita de ítemdc.identifier.citationCurrent Pharmaceutical Desing Volumen: 22 Número: 36 Páginas: 5515-5525 (2016)es_ES
Identifierdc.identifier.issn1381-6128
Identifierdc.identifier.other10.2174/1381612822666160722100534
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/145878
Abstractdc.description.abstractPolycystic ovary syndrome (PCOS) is a highly prevalent endocrine metabolic disorder and is presently considered a family pathology. It is associated with obesity, insulin resistance and metabolic syndrome. Racial, ethnic and environmental factors may be important in determining the clinical manifestations of this syndrome. Polycystic ovary syndrome is an exclusion diagnosis and, therefore, should be distinguished from the physiological changes typical for the age and from other hyperandrogenic disorders. Early diagnosis is important since this syndrome is associated with reproductive, oncologic and metabolic risks. Interestingly, the clinical features of this disorder may change throughout the lifespan of a PCOS woman, starting from adolescence to postmenopausal age. During the first decades of life the main features are in the reproductive area, while later in life metabolic abnormalities are more evident. While the assessment of insulin resistance is not part of the diagnosis of PCOS, it has been demonstrated that this metabolic component appears early in life and persists over time. Moreover during puberty and pregnancy, insulin resistance is exacerbated. Pregnancy represents an important stage, as the offspring of these patients may be reprogrammed and inherit some of the metabolic and reproductive features of their mothers. In the present review, we will focus on several metabolic aspects of the PCOS condition at different stages of life in a Chilean populationes_ES
Patrocinadordc.description.sponsorshipFondo Nacional de Desarrollo Cientifico y Tecnologico (National Fund for Scientific and Technological Research) Fondecyt 1970291 1030487 1050915 1071007 1110864 1151531 SOCHED (Chilean Society of Endocrinology and Diabetes) 2009-48 05 Alexander von Humboldt Foundationes_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherBentham Sciencees_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceCurrent Pharmaceutical Desinges_ES
Keywordsdc.subjectPolycystic ovary syndromees_ES
Keywordsdc.subjectInsulin resistancees_ES
Keywordsdc.subjectMetabolic syndromees_ES
Keywordsdc.subjectPro-inflammatory factorses_ES
Keywordsdc.subjectGestational diabeteses_ES
Keywordsdc.subjectSmall/large for gestational agees_ES
Keywordsdc.subjectPCOS offspringes_ES
Keywordsdc.subjectLong term complicationses_ES
Títulodc.titleMetabolic Features Across the Female Life Span in Women with PCOSes_ES
Document typedc.typeArtículo de revista
dcterms.accessRightsdcterms.accessRightsAcceso a solo metadatoses_ES
Catalogueruchile.catalogadorapces_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile